BMY
- Bristol-Myers Squibb Company
()
Overview
Company Summary
Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical company that discovers, develops, and manufactures pharmaceutical products to address serious diseases. It operates in various therapeutic areas, including oncology, cardiovascular, immunoscience, and fibrosis.
The company conducts extensive research and development activities to discover and develop new medicines that can improve patient outcomes and provide innovative treatment options. This involves investing in cutting-edge technologies and collaborating with external partners such as academic institutions, healthcare organizations, and biotechnology companies.
Bristol-Myers Squibb is well-known for its expertise in oncology, where it has developed several groundbreaking therapies for the treatment of various types of cancers, such as Opdivo and Yervoy. These drugs are part of the company's immuno-oncology portfolio and have significantly improved the treatment landscape for patients with advanced cancers.
In addition to oncology, Bristol-Myers Squibb also focuses on cardiovascular therapies, developing medications to address critical conditions like heart disease, stroke, and thrombosis.
The company's immunoscience division focuses on studying and developing treatments for immune-mediated diseases, including rheumatoid arthritis, psoriasis, and lupus. They aim to provide patients with targeted therapies that can help manage these chronic conditions.
Furthermore, Bristol-Myers Squibb has a division dedicated to research and development in fibrosis, with a focus on liver fibrosis, a condition that can lead to cirrhosis and liver failure. The aim is to develop therapies that can slow down or reverse the progression of fibrosis and improve patient outcomes.
Overall, Bristol-Myers Squibb is committed to leveraging scientific innovation to tackle challenging diseases, improve patient outcomes, and make a positive impact on global healthcare.